PARTNERSHIP OPPORTUNITIES
Maximize Your Business Prospects in the Rapidly Growing Retinal Imaging Field
With the global fluorescein angiography market estimated to reach USD 785.15 million by 2030, and retinal R&D scientists still on the hunt for the optimal imaging tools that can aid their drug development, now is the time to join this annual industry-dedicated forum uniting 80+ senior decision makers with preclinical, clinical R&D, retinal imaging and diagnostic expertise.
Meet and network with ophthalmic drug developers from Astellas, Boehringer Ingelheim, Genentech and Novartis, and learn what they require from retinal imaging tools, AI algorithms and preclinical and clinical CROs to strategize how you can raise brand awareness and generate revenue for your business
This Niche Community of Retinal Imaging Experts Needs:
Retinal Imaging Device & Technology Providers
Artificial Intelligence & Screening Tools
Preclinical & Clinical CROs with Expertise in Ophthalmology
Data Reading Centres
Why Partner?
Benefit from Market Intelligence in Retinal Imaging Biomarkers & Endpoints
Discover new AI algorithms developed by industry experts, such as Genentech, Boston Image Reading Centre and Ocuphire, to generate new business opportunities and refresh your target customer list
Network with Industry Experts from the likes of Novartis, Genentech & Astellas
Secure invaluable facetime and generate new business with key decision makers as they require improved retinal imaging tools to accelerate patient selection for their clinical trials to showcase drug efficacy, through structured speed networking and pre-organized 1-2-1 meetings
Generate Commercial Collaborations with Senior Decision Makers
Have a wish list of your choice contacted in advance of the event to ensure that your hottest prospects are in the room and that you are set up for success in securing quality leads and contacts for desired commercial gain
Raise Brand Awareness within the Retinal Imaging & Ophthalmic R&D Community
Increase your market share with the retinal imaging and ophthalmic R&D KOLs through unique branding formats, such as exhibition booths, lead partnership options, or a dedicated presentation to show how your services can help progress their drugs into the clinic
Audience Breakdown:
